These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 18549318
1. Maximizing dendritic cell migration in cancer immunotherapy. Verdijk P, Aarntzen EH, Punt CJ, de Vries IJ, Figdor CG. Expert Opin Biol Ther; 2008 Jul; 8(7):865-74. PubMed ID: 18549318 [Abstract] [Full Text] [Related]
2. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Dekaban GA, Hamilton AM, Fink CA, Au B, de Chickera SN, Ribot EJ, Foster PJ. Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013 Jul; 5(5):469-83. PubMed ID: 23633389 [Abstract] [Full Text] [Related]
3. Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. Zhang X, de Chickera SN, Willert C, Economopoulos V, Noad J, Rohani R, Wang AY, Levings MK, Scheid E, Foley R, Foster PJ, Dekaban GA. Cytotherapy; 2011 Nov; 13(10):1234-48. PubMed ID: 21923625 [Abstract] [Full Text] [Related]
4. Junctional adhesion molecules mediate transendothelial migration of dendritic cell vaccine in cancer immunotherapy. Roh SE, Jeong Y, Kang MH, Bae YS. Cancer Lett; 2018 Oct 10; 434():196-205. PubMed ID: 30055289 [Abstract] [Full Text] [Related]
5. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. Barratt-Boyes SM, Zimmer MI, Harshyne LA, Meyer EM, Watkins SC, Capuano S, Murphey-Corb M, Falo LD, Donnenberg AD. J Immunol; 2000 Mar 01; 164(5):2487-95. PubMed ID: 10679086 [Abstract] [Full Text] [Related]
6. Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy. Jin H, Qian Y, Dai Y, Qiao S, Huang C, Lu L, Luo Q, Chen J, Zhang Z. Theranostics; 2016 Mar 01; 6(11):2000-2014. PubMed ID: 27698936 [Abstract] [Full Text] [Related]
7. Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses. Seyfizadeh N, Muthuswamy R, Mitchell DA, Nierkens S, Seyfizadeh N. Crit Rev Oncol Hematol; 2016 Nov 01; 107():100-110. PubMed ID: 27823637 [Abstract] [Full Text] [Related]
14. Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy. Kim JY, Kim YJ, Kim JS, Ryu HS, Lee HK, Kang JS, Kim HM, Hong JT, Kim Y, Han SB. Cancer Lett; 2011 Dec 27; 313(2):226-34. PubMed ID: 21974804 [Abstract] [Full Text] [Related]
16. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ. Immunity; 2006 Feb 27; 24(2):203-15. PubMed ID: 16473832 [Abstract] [Full Text] [Related]
17. The use of dendritic cells for cancer vaccination. Esche C, Shurin MR, Lotze MT. Curr Opin Mol Ther; 1999 Feb 27; 1(1):72-81. PubMed ID: 11249687 [Abstract] [Full Text] [Related]